Ppargc1A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PPARGC1A (PPARG Coactivator 1 Alpha / PGC-1α) is a gene encoding a transcriptional coactivator that regulates mitochondrial biogenesis, energy metabolism, and oxidative stress response.
| Property |
Value |
| Gene Symbol |
PPARGC1A |
| Full Name |
PPARG Coactivator 1 Alpha |
| Chromosomal Location |
4p15.31 |
| NCBI Gene ID |
10891 |
| OMIM ID |
604517 |
| Ensembl ID |
ENSG00000109819 |
| UniProt ID |
Q9UBX2 |
| Associated Diseases |
Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Type 2 Diabetes, Metabolic Syndrome |
PPARGC1A encodes PGC-1α (PPAR gamma coactivator 1-alpha), a transcriptional coactivator that serves as a master regulator of mitochondrial biogenesis and cellular energy metabolism.
- Transcriptional Coactivator: Binds to nuclear receptors and transcription factors to enhance their activity
- Mitochondrial Biogenesis: Activates NRF-1, NRF-2, and ERRα to increase mitochondrial DNA replication and protein synthesis
- Oxidative Phosphorylation: Upregulates genes involved in the electron transport chain
- Fatty Acid Oxidation: Enhances expression of genes for β-oxidation
- Gluconeogenesis: Regulates hepatic glucose production
- Thermogenesis: Controls brown adipose tissue function
PGC-1α is expressed in tissues with high metabolic demand:
- Brain: Neurons (especially in substantia nigra, hippocampus), astrocytes
- Skeletal Muscle: High expression in oxidative (slow-twitch) fibers
- Heart: Cardiac muscle
- Brown Adipose Tissue: Thermogenic adipocytes
- Liver: Hepatocytes
In the brain, PGC-1α is particularly important in:
- Dopaminergic neurons (high metabolic demand)
- Hippocampal neurons (cognitive function)
- Cerebellar Purkinje cells
PGC-1α dysfunction contributes to AD:
- Reduced PGC-1α in AD brain
- Mitochondrial dysfunction and energy deficit
- Aβ-induced mitochondrial damage
- Therapeutic potential: PGC-1α activators improve cognition in models
PGC-1α is crucial for dopaminergic neuron survival:
- Mitochondrial complex I deficiency in PD
- PGC-1α protects against MPTP/6-OHDA toxicity
- LRRK2 regulates PGC-1α activity
- Gene therapy approaches in development
PGC-1α is downregulated in HD:
- Mutant huntingtin impairs PGC-1α function
- Mitochondrial dysfunction in HD
- Restoring PGC-1α improves phenotypes in models
- Therapeutic target for HD
- Type 2 Diabetes: PGC-1α variants associated with insulin resistance
- Obesity: Reduced PGC-1α in adipose tissue
- Metabolic Syndrome: Therapeutic target
| Compound |
Status |
Mechanism |
| AICAR |
Research |
AMPK activation → PGC-1α |
| Resveratrol |
Dietary supplement |
SIRT1 activation → PGC-1α deacetylation |
| Bezafibrate |
FDA approved (lipids) |
PPAR activation → PGC-1α |
| Metformin |
FDA approved (diabetes) |
AMPK activation |
| Exercise |
Clinical |
PGC-1α induction |
- AAV-PPARGC1A for neurodegenerative diseases
- SIRT1 activators to enhance PGC-1α activity
- Wareski P et al. (2009) PGC-1alpha and PGC-1beta regulate mitochondrial density in neurons. J Biol Chem. PMID: 19211836
- St-Pierre J et al. (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. PMID: 16547501
- Cui L et al. (2006) Transcriptional activation of human PGC-1alpha by Huntington disease protein. Cell. PMID: 16547502
The study of Ppargc1A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Wareski P, et al. PGC-1alpha and PGC-1beta regulate mitochondrial density in neurons. J Biol Chem. 2009;284(32):21379-21385. PMID:19211836
- St-Pierre J, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 2006;127(2):397-408. PMID:16547501
- Cui L, et al. Transcriptional activation of human PGC-1alpha by Huntington disease protein. Cell. 2006;127(2):409-422. PMID:16547502
- Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy metabolism, and metabolic diseases. Physiol Rev. 2007;87(2):507-538. PMID:17499144
- Lin J, et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature. 2002;418(6899):797-801. PMID:12181572